Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction (Q46562775)

23 December 2017

title

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction (English)

1 reference

23 December 2017

D. A. Dichek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9212099

3 September 2024

S. Baekkeskov

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9212099

3 September 2024

S. M. Kang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9212099

3 September 2024

D. B. Schneider

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9212099

3 September 2024

Z. Lin

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9212099

3 September 2024

D. Hanahan

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9212099

3 September 2024

P. G. Stock

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9212099

3 September 2024

language of work or name

English

0 references

publication date

1 July 1997

1 reference

23 December 2017

number of pages

1 reference

full work available at URL

inferred from page(s)

http://www.nature.com/articles/nm0797-738

1 reference

https://api.crossref.org/works/10.1038/NM0797-738

http://www.nature.com/articles/nm0797-738.pdf

3 September 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/NM0797-738

3 September 2024

1 reference

23 December 2017

volume

1 reference

23 December 2017

issue

1 reference

23 December 2017

page(s)

738-743

1 reference

23 December 2017

Fas and Fas ligand: a death factor and its receptor.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

The role of APO-1-mediated apoptosis in the immune system

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

https://api.crossref.org/works/10.1038%2FNM0797-738

1 reference

7 January 2021

Fas ligand and immune evasion

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Fas and Fas ligand: lpr and gld mutations

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

A role for CD95 ligand in preventing graft rejection

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Pancreas and islet transplantation. II. Clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Mouse islet cell lysis mediated by interleukin-1-induced Fas.

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

The role of Fas in autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Esterase activity in leukocytes demonstrated by the use of naphthol AS-D chloroacetate substrate

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

T-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous pancreatic genes in thymus

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Sexual dimorphism of pancreatic beta-cell degeneration in transgenic mice expressing an insulin-ras hybrid gene

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Antitumor effect of locally produced CD95 ligand

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Fas-mediated stimulation induces IL-8 secretion by rheumatoid arthritis synoviocytes independently of CPP32-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Interleukin-8, a chemotactic and inflammatory cytokine

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Expression of the functional soluble form of human fas ligand in activated lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Metalloproteinase-mediated release of human Fas ligand

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Role of early region 3 (E3) in pathogenesis of adenovirus disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Identification of a cis-acting sequence in the human plasminogen activator inhibitor type-1 gene that mediates transforming growth factor-beta1 responsiveness in endothelium in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNM0797-738

7 January 2021

Diabetes research (Edinburgh, Scotland)

WA Hansen

1989

1 reference

https://api.crossref.org/works/10.1038/NM0797-738

3 September 2024

Identifiers

DOI

10.1038/NM0797-738

1 reference

23 December 2017

1 reference

23 December 2017